PLoS ONE (Jan 2011)

Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression.

  • Elena I Fomchenko,
  • Joseph D Dougherty,
  • Karim Y Helmy,
  • Amanda M Katz,
  • Alexander Pietras,
  • Cameron Brennan,
  • Jason T Huse,
  • Ana Milosevic,
  • Eric C Holland

DOI
https://doi.org/10.1371/journal.pone.0020605
Journal volume & issue
Vol. 6, no. 7
p. e20605

Abstract

Read online

BackgroundGliomas are thought to form by clonal expansion from a single cell-of-origin, and progression-associated mutations to occur in its progeny cells. Glioma progression is associated with elevated growth factor signaling and loss of function of tumor suppressors Ink4a, Arf and Pten. Yet, gliomas are cellularly heterogeneous; they recruit and trap normal cells during infiltration.Methodology/principal findingsWe performed lineage tracing in a retrovirally mediated, molecularly and histologically accurate mouse model of hPDGFb-driven gliomagenesis. We were able to distinguish cells in the tumor that were derived from the cell-of-origin from those that were not. Phenotypic, tumorigenic and expression analyses were performed on both populations of these cells. Here we show that during progression of hPDGFb-induced murine gliomas, tumor suppressor loss can expand the recruited cell population not derived from the cell-of-origin within glioma microenvironment to dominate regions of the tumor, with essentially no contribution from the progeny of glioma cell-of-origin. Moreover, the recruited cells can give rise to gliomas upon transplantation and passaging, acquire polysomal expression profiles and genetic aberrations typically present in glioma cells rather than normal progenitors, aid progeny cells in glioma initiation upon transplantation, and become independent of PDGFR signaling.Conclusions/significanceThese results indicate that non-cell-of-origin derived cells within glioma environment in the mouse can be corrupted to become bona fide tumor, and deviate from the generally established view of gliomagenesis.